Table 2.
Experimental treatments1 | SEM | P-value2 | ||||
---|---|---|---|---|---|---|
Item | Con | Arg | LPS | LPS + Arg | ||
Growth hormone, μg/L | ||||||
0-h preinfusion | 18.60 | 19.05 | 19.37 | 17.37 | 2.68 | 0.964 |
3-h postinfusion | 17.26 | 16.78 | 19.39 | 21.6 | 2.29 | 0.374 |
6-h postinfusion | 17.01 | 16.42 | 18.92 | 19.69 | 2.19 | 0.657 |
Insulin, mIU/L | ||||||
0-h preinfusion | 26.88 | 23.52 | 23.70 | 26.43 | 3.70 | 0.780 |
3-h postinfusion | 23.30b | 34.80a | 26.33ab | 30.25ab | 3.51 | 0.071 |
6-h postinfusion | 26.24 | 32.14 | 26.35 | 30.34 | 3.27 | 0.390 |
Prolactin, ng/L | ||||||
0-h preinfusion | 286.18b | 473.20a | 334.53b | 373.50ab | 44.44 | 0.014 |
3-h postinfusion | 303.32 | 420.02 | 306.22 | 408.48 | 50.17 | 0.695 |
6-h postinfusion | 285.74 | 306.22 | 415.06 | 401.63 | 56.73 | 0.239 |
a,bValues within a row with different letters differ (P < 0.05).
1Treatments: Saline (Con); LPS (lipopolysaccharide, 0.2 μg/kg BW per day); Arg (Arginine, 18 g/d); LPS + Arginine (0.2 μg/kg BW per day of LPS and 18 g/d of Arg).
2Probability of a difference among the 4 treatments.